These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 20018473)

  • 1. Identification and characterization of degradation products of irbesartan using LC-MS/TOF, MS(n), on-line H/D exchange and LC-NMR.
    Shah RP; Sahu A; Singh S
    J Pharm Biomed Anal; 2010 Apr; 51(5):1037-46. PubMed ID: 20018473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LC and LC-MS/TOF studies on stress degradation behaviour of candesartan cilexetil.
    Mehta S; Shah RP; Priyadarshi R; Singh S
    J Pharm Biomed Anal; 2010 Jul; 52(3):345-54. PubMed ID: 19505786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LC, LC-MS/TOF and MS(n) studies for the identification and characterization of degradation products of nelfinavir mesylate.
    Tiwari RN; Bonde CG
    J Pharm Biomed Anal; 2011 Jun; 55(3):435-45. PubMed ID: 21392920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of a photolytic degradation product of telmisartan using LC-MS/TOF, LC-MSn, LC-NMR and on-line H/D exchange mass studies.
    Shah RP; Singh S
    J Pharm Biomed Anal; 2010 Nov; 53(3):755-61. PubMed ID: 20554147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stress degradation studies on lornoxicam using LC, LC-MS/TOF and LC-MSn.
    Modhave DT; Handa T; Shah RP; Singh S
    J Pharm Biomed Anal; 2011 Nov; 56(3):538-45. PubMed ID: 21757313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradation study of irbesartan: Isolation and structural elucidation of novel degradants.
    Mutha VVSRNAK; Guduru S; Kaliyaperumal M; Rumalla CS; Maddi SR; Korupolu RB; Gajbhiye SB
    J Pharm Biomed Anal; 2018 Aug; 157():180-188. PubMed ID: 29803909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of forced decomposition behavior of lamivudine using LC, LC-MS/TOF and MS(n).
    Bedse G; Kumar V; Singh S
    J Pharm Biomed Anal; 2009 Jan; 49(1):55-63. PubMed ID: 19022602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of stress degradation products of fosinopril by using LC-MS/TOF, MS(n) and on-line H/D exchange.
    Narayanam M; Singh S
    J Pharm Biomed Anal; 2014 Apr; 92():135-43. PubMed ID: 24518132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of LC-MS/TOF, LC-MS(n), NMR and LC-NMR in characterization of stress degradation products: Application to cilazapril.
    Narayanam M; Sahu A; Singh S
    J Pharm Biomed Anal; 2015; 111():190-203. PubMed ID: 25890215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forced degradation of fingolimod: effect of co-solvent and characterization of degradation products by UHPLC-Q-TOF-MS/MS and 1H NMR.
    Patel PN; Kalariya PD; Gananadhamu S; Srinivas R
    J Pharm Biomed Anal; 2015 Nov; 115():388-94. PubMed ID: 26279369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of stressed degradation products of prulifloxacin using LC-ESI-MS/Q-TOF, MSn experiments: development of a validated specific stability-indicating LC-MS method.
    Raju B; Ramesh M; Srinivas R; Raju SS; Venkateswarlu Y
    J Pharm Biomed Anal; 2011 Nov; 56(3):560-8. PubMed ID: 21783336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategy for identification and characterization of small quantities of drug degradation products using LC and LC-MS: application to valsartan, a model drug.
    Mehta S; Shah RP; Singh S
    Drug Test Anal; 2010 Feb; 2(2):82-90. PubMed ID: 20878890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of forced degradation products of tamsulosin using liquid chromatography/electrospray ionization tandem mass spectrometry.
    Namdev D; Borkar RM; Raju B; Kalariya PD; Rahangdale VT; Gananadhamu S; Srinivas R
    J Pharm Biomed Anal; 2014 Jan; 88():245-55. PubMed ID: 24083958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of forced degradation behavior of enalapril maleate by LC and LC-MS and development of a validated stability-indicating assay method.
    Bhardwaj SP; Singh S
    J Pharm Biomed Anal; 2008 Jan; 46(1):113-20. PubMed ID: 17964751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of stress degradation products of duloxetine hydrochloride employing LC-UV/PDA and LC-MS/TOF studies.
    Chadha R; Bali A; Bansal G
    J Pharm Biomed Anal; 2016 Mar; 121():39-55. PubMed ID: 26775018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of stress degradation products of benazepril by using sophisticated hyphenated techniques.
    Narayanam M; Sahu A; Singh S
    J Chromatogr A; 2013 Jan; 1271(1):124-36. PubMed ID: 23237710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LC-MS/TOF, LC-MSn, on-line H/D exchange and LC-NMR studies on rosuvastatin degradation and in silico determination of toxicity of its degradation products: a comprehensive approach during drug development.
    Shah RP; Sahu A; Singh S
    Anal Bioanal Chem; 2013 Apr; 405(10):3215-31. PubMed ID: 23386001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of stressed degradation products of metoprolol using LC/Q-TOF-ESI-MS/MS and MS(n) experiments.
    Borkar RM; Raju B; Srinivas R; Patel P; Shetty SK
    Biomed Chromatogr; 2012 Jun; 26(6):720-36. PubMed ID: 21989963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MS2/TOF and LC-MS/TOF studies on toremifene to characterize its forced degradation products.
    Bansal G; Maddhesia PK; Bansal Y
    Analyst; 2011 Dec; 136(24):5218-28. PubMed ID: 22013582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of stress degradation products of dronedarone hydrochloride employing LC-UV/PDA, LC-MS/TOF and MS(n) studies.
    Chadha R; Bali A; Bansal G
    J Pharm Biomed Anal; 2016 Jan; 118():139-148. PubMed ID: 26547261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.